Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL16037372

N.Nc1cnccc1-c1ncccc1F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 7/20 0.49
GABRB3 P28472 7/20 0.49
GABRA5 P31644 7/20 0.49
GABRA3 P34903 7/20 0.49
GABRA1 P14867 6/20 0.49
GPBAR1 Q8TDU6 1/20 0.42
PIM1 P11309 2/20 0.37
PIM3 Q86V86 2/20 0.37
PIM2 Q9P1W9 2/20 0.37
NUDT1 P36639 1/20 0.36
TGFBR1 P36897 1/20 0.36
TGFBR2 P37173 1/20 0.36
EGFR P00533 1/20 0.35
AOC1 P19801 2/20 0.34
AOC3 Q16853 2/20 0.34
CYP2A6 P11509 1/20 0.34
FEN1 P39748 1/20 0.34
GSK3B P49841 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30444888 0.98 GABRG2 (0.50) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL32667309 0.85 GABRG2 (0.47) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL30442955 0.78 CYP2A6 (0.54) GPBAR1TGFBR1AOC1AOC3CYP2A6
SCHEMBL18269927 0.78 GAA (0.46) AOC1AOC3CYP2A6
SCHEMBL15778479 0.78 CYP2A6 (0.54) GPBAR1TGFBR1AOC1AOC3CYP2A6
SCHEMBL12098065 0.78 LOXL2 (0.50) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL15778019 0.76 MAPT (0.44) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL29890929 0.76 MAPT (0.44) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL13149262 0.75 ALDH1A1 (0.46) GPBAR1PIM1PIM3PIM2NUDT1
SCHEMBL29939393 0.75 ALDH1A1 (0.46) GPBAR1PIM1PIM3PIM2NUDT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240116930-A1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2024-04-11 US disclosed
US-11820770-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-20220213095-A1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2022-07-07 US disclosed
US-11225478-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2022-01-18 US disclosed
CN-110003200-B P2X7 modulators 詹森药业有限公司 2021-11-26 CN disclosed
US-20200325138-A1 P2X7 Modulators JANSSEN PHARMACEUTICA NV (BE) 2020-10-15 US disclosed
US-10703749-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2020-07-07 US disclosed
EP-3495365-A1 P2X7 MODULATORS Janssen Pharmaceutica NV (BE) 2019-06-12 EP disclosed
US-20190092770-A1 P2X7 Modulators JANSSEN PHARMACEUTICA NV (BE) 2019-03-28 US disclosed
US-10150765-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2018-12-11 US disclosed
US-10112937-B2 P2X7 modulators and methods of use JANSSEN PHARMACEUTICA NV (BE) 2018-10-30 US disclosed
EP-2970267-B3 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-05-30 EP disclosed
EP-3239151-A1 P2X7 MODULATORS Janssen Pharmaceutica NV (BE) 2017-11-01 EP disclosed
EP-2970267-B1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2017-05-24 EP disclosed
US-20160376271-A1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV 2016-12-29 US disclosed
US-9464084-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2016-10-11 US disclosed
US-20160039809-A1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2016-02-11 US disclosed
US-20150322062-A1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-11-12 US disclosed
US-9066946-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2015-06-30 US disclosed
US-20140275015-A1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200325138-A1 P2X7 Modulators P2RX2, P2RX7, P2RY2 GABRG2 496/4885GABRB3 315/4885GABRA5 547/4885
US-10150765-B2 P2X7 modulators P2RX2, P2RX7, P2RY2 GABRG2 496/4885GABRB3 315/4885GABRA5 547/4885
US-20160376271-A1 P2X7 MODULATORS P2RX2, P2RX7, P2RY2 GABRG2 496/4885GABRB3 315/4885GABRA5 547/4885
US-20190092770-A1 P2X7 Modulators P2RX2, P2RX7, P2RY2 GABRG2 496/4885GABRB3 315/4885GABRA5 547/4885
US-11225478-B2 P2X7 modulators P2RX2, P2RX7, P2RY2 GABRG2 496/4885GABRB3 315/4885GABRA5 547/4885
US-10112937-B2 P2X7 modulators and methods of use P2RX2, P2RX7, P2RX5 GABRG2 502/4885GABRB3 353/4885GABRA5 422/4885
US-20160039809-A1 P2X7 MODULATORS P2RX2, P2RX7, P2RX5 GABRG2 554/4885GABRB3 359/4885GABRA5 520/4885
US-20150322062-A1 P2X7 MODULATORS P2RX2, P2RX7, P2RY2 GABRG2 496/4885GABRB3 315/4885GABRA5 547/4885
US-11820770-B2 P2X7 modulators P2RX2, P2RX7, P2RY2 GABRG2 496/4885GABRB3 315/4885GABRA5 547/4885
US-20220213095-A1 P2X7 MODULATORS P2RX2, P2RX7, P2RY2 GABRG2 496/4885GABRB3 315/4885GABRA5 547/4885
US-20240116930-A1 P2X7 MODULATORS P2RX2, P2RX7, P2RY2 GABRG2 496/4885GABRB3 315/4885GABRA5 547/4885
US-10703749-B2 P2X7 modulators P2RX2, P2RX7, P2RY2 GABRG2 496/4885GABRB3 315/4885GABRA5 547/4885
US-20140275015-A1 P2X7 MODULATORS P2RX2, P2RX7, P2RY2 GABRG2 496/4885GABRB3 315/4885GABRA5 547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.